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Abstract
Background: Understanding how mesenchymal cells arise from epithelial cells could have a strong
impact in unveiling mechanisms of epithelial cell plasticity underlying kidney regeneration and
repair.
In primary human tubular epithelial cells (HUTEC) under different TGFβ1 concentrations we had
observed epithelial-to-mesenchymal transition (EMT) but not epithelial-myofibroblast
transdifferentiation. We hypothesized that the process triggered by TGFβ1 could be a
dedifferentiation event. The purpose of this study is to comprehensively delineate genetic programs
associated with TGFβ1-driven EMT in our in vitro model using gene expression profile on large-
scale oligonucleotide microarrays.
Results: In HUTEC under TGFβ1 stimulus, 977 genes were found differentially expressed. Thirty
genes were identified whose expression depended directly on TGFβ1 concentration. By mapping
the differentially expressed genes in the Human Interactome Map using Cytoscape software, we
identified a single scale-free network consisting of 2630 interacting proteins and containing 449
differentially expressed proteins. We identified 27 hub proteins in the interactome with more than
29 edges incident on them and encoded by differentially expressed genes. The Gene Ontology
a n a l y s i s  s h o w e d  a n  e x c e s s  o f  up-regulated proteins involved in biological processes, such as
"morphogenesis", "cell fate determination" and "regulation of development", and the most up-
regulated genes belonged to these categories. In addition, 267 genes were mapped to the KEGG
pathways and 14 pathways with more than nine differentially expressed genes were identified. In
our model, Smad signaling was not the TGFβ1 action effector; instead, the engagement of RAS/
MAPK signaling pathway seems mainly to regulate genes involved in the cell cycle and proliferation/
apoptosis.
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Conclusion: Our present findings support the hypothesis that context-dependent EMT generated
in our model by TGFβ1 might be the outcome of a dedifferentiation. In fact: 1) the principal
biological categories involved in the process concern morphogenesis and development; 2) the most
up-regulated genes belong to these categories; and, finally, 3) some intracellular pathways are
involved, whose engagement during kidney development and nephrogenesis is well known. These
long-term effects of TGFβ1 in HUTEC involve genes that are highly interconnected, thereby
generating a scale-free network that we named the "TGFβ1 interactome", whose hubs represent
proteins that may have a crucial role for HUTEC in response to TGFβ1.
Background
Epithelial-to-mesenchymal transition (EMT) of renal
tubular cells is a fundamental sign of epithelial cell plas-
ticity in physiological processes such as regeneration and
wound healing, but it also characterizes pathological con-
ditions such as fibrosis and carcinogenesis.
The adult mammalian renal tubular epithelium exists in a
relatively quiescent to slowly replicating state, but has
great potential for regenerative morphogenesis following
severe ischemic or toxic injury [1]. Dedifferentiation, i.e.
the acquisition of mesenchymal markers such as vimentin
and N-cadherin, seems to represent a crucial step in the
recovery of tubular integrity and precedes the reconstitu-
tion of a well-differentiated morphology. In the adult kid-
ney, however, the tubular cells' acquisition of a
mesenchymal phenotype represents one of the crucial
steps towards transdifferentiation into myofibroblasts,
the effector cells of tubulo-interstitial fibrosis [2].
Transforming growth factor β1 (TGFβ1) is a key modula-
tor of EMT in a variety of epithelial cells, but is also capa-
ble of inducing the myofibroblast phenotype, i.e. the
acquisition of alpha smooth muscle actin (αSMA) micro-
filaments in fibroblasts during wound healing, in mesang-
ial cells in culture and in renal tubular cells [3].
TGFβ1-induced EMT appears to depend primarily on
intact Smad signaling. To date, Smad proteins are the only
TGFβ1 receptor substrates with a demonstrated ability to
propagate signals [4]. It is now becoming evident, how-
ever, that EMT is not a uniform process. Its role and fea-
tures clearly differ, depending on the physiological
context and type of epithelia (developmental EMT, onco-
genic EMT, non-oncogenic EMT) [5].
Using primary human tubular epithelial cells (HUTEC),
we demonstrated that chronic exposure to TGFβ1
prompted morphological, molecular and biochemical
changes towards a mesenchymal phenotype, but this gave
rise to no de novo expression of αSMA gene or myofibrob-
last phenotype [6]. We hypothesized that the process trig-
gered by TGFβ1 in our model is a dedifferentiation event
that may be part of the vital plasticity of renal tubular
cells.
Our results prompted us to further characterize this EMT
process. Since microarray technology powerfully moni-
tors gene expression and has led to the discovery of path-
ways regulating complex biological processes, we
explored the molecular mechanisms underlying this tran-
sition using this approach. A global view of the EMT proc-
ess was obtained identifying the Gene Ontology (GO)
classes enriched by differentially expressed genes and ana-
lyzing KEGG pathways involved in signal transduction. To
obtain an overview of their topological properties, we also
mapped differentially expressed proteins in the human
interactome map using Cytoscape software. This analysis
enabled us to establish that about 50% of the genes up-
and down-regulated by TGFβ1 were strongly intercon-
nected and formed a large network that we named the
"TGFβ1 interactome".
Results
At genome-wide level, we investigated the expression pro-
file changes occurring in the EMT of primary HUTEC
under chronic TGFβ1 treatment. Our in vitro model of
human renal EMT has been described in detail elsewhere
[6]. By immunocytochemistry, we demonstrated that, in
addition to the front-end to back-end cell morphology,
TGFβ1 can induce a markedly dose-dependent up-regu-
lated expression of mesenchymal markers, including col-
lagen III, with a parallel drop in the expression of
epithelial markers such as E-cadherin and cytokeratin. In
our in vitro model, however, TGFβ1 stimulation did not
induce conversion to the myofibroblast phenotype [6].
Cultures treated for 4 days with 5–10–50 ng/ml of TGFβ1
were considered for the microarray studies. We refer to
these experiments as "coll-5 ng", "coll-10 ng", "coll-50
ng", "plast-5 ng", "plast-10 ng" and "plast 50 ng". To
ascertain the role of the substrate, the expression profile of
cells cultured on plastic plates was also compared with
that of cells grown on collagen I in basal conditions; we
refer to this experiment as "coll-vs-plast".BMC Genomics 2007, 8:383 http://www.biomedcentral.com/1471-2164/8/383
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Each of the seven experiments was performed in dupli-
cate, differentially expressed genes were obtained inde-
pendently for each comparison and results are given in the
Additional file 1. Of ~21000 unique genes of the human
oligo chip, we found 977 differentially expressed, repre-
sented by 993 spots (Additional file 1).
Since our experiment had a typical dose-response design,
the expected effect was a dose-related increase in differen-
tially expressed genes, as shown in Figure 1. Only the up-
regulated genes increased considerably, however, going
from 5 to 50 ng/ml of TGFβ1, while the down-regulated
genes remained much the same in this range. This result
did not depend on the cell-growing substrate, though it
was more prominent for collagen I. Probably the higher
the TGFβ1 concentration, the greater the number of genes
exceeding the significance threshold.
To establish whether the differentially expressed genes in
each experiment were coordinately regulated, we com-
pared expression ratios using cluster analysis (Figure 2).
We identified four clusters of coordinately regulated genes
that were common to the six experiments, demonstrating
that the expression profile is similar for all the TGFβ1 con-
centrations whatever the substrate used. This finding also
means that no illegitimate induction took place and
seems to support the suggestion that more differentially
expressed genes are obtained with the higher dosages
because more genes exceed the threshold, not because
there are more "new" genes.
Number of differentially expressed genes in each experimen- tal condition Figure 1
Number of differentially expressed genes in each 
experimental condition. Cells were grown on plastic 
(plast) or collagen I (coll) plates and exposed to different 
TGFβ1 concentrations (5–10–50 ng/ml). The last experiment 
(plast vs. coll) is the comparison between cells grown on the 
two different substrates and not treated with TGFβ1.
Cluster analysis of the differentially expressed genes using  TMEV software Figure 2
Cluster analysis of the differentially expressed genes 
using TMEV software. The 993 genes in Additional file 1 
are clustered on the basis of the log2 expression ratio. Up-
regulated and down-regulated genes are colored in red and 
green, respectively. Columns refer to the seven experiments 
performed using different TGFβ1 concentrations (5–10–50 
ng/ml) and substrates (collagen type I and plastic). Note that 
genes are grouped in large blocks, in which they tend to be 
up- or down-regulated in all the first six experiments.BMC Genomics 2007, 8:383 http://www.biomedcentral.com/1471-2164/8/383
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Given these results, a global list of 919 differentially
expressed genes, excluding those identified in the "coll-vs-
plast" experiment, was considered for the GO, KEGG and
other analyses.
We performed a statistical analysis using the SAM software
to assign a significance level to the genes whose expres-
sion depended on the TGFβ1 dosage. We identified 25
genes related directly and five genes related inversely to
the TGFβ1 dosage with a q value of zero, indicating a
strong correlation between dosages and expression levels.
The complete list of the genes is given in Table 1. To avoid
false negatives, we applied very stringent criteria in the sta-
tistical analysis, selecting only genes with a q value of zero
– hence their small number. Five of these genes were also
identified by Zavadil et al. [7] in time-dependent microar-
ray experiments on human keratinocytes. THBS1, WEE1,
PLS3 and ITGAV expression was increased in both our
own dose-dependent experiments and in Zavadil's time-
course experiments, while MAL expression was decreased,
suggesting the existence of a common regulatory mecha-
nism regardless of the cell type.
The large number of genes regulated by TGFβ1 makes it
difficult to understand the role of this growth factor in the
EMT process using a gene-by-gene study. We opted for an
analysis designed to comprehensively delineate the
genetic programs associated with EMT in response to
TGFβ1.
The biological significance of differentially expressed
genes was explored using two databases as resources, i.e.
the GO and the Kyoto Encyclopedia of Genes and
Genomes (KEGG) maps (see Material and Methods).
Among the categories of biological processes (BP), six fea-
tured a large number of down-regulated genes and 20
contained a large number of up-regulated genes (Figure
3B). Among the latter, we found proteins involved in cell
proliferation, the cell cycle and cell growth regulation, the
cytoskeleton and protein transport. Among the cell com-
Table 1: Dose response genes identified using SAM software.
GB accession ID EntrezGene ID Gene Symbol Description Score(d) R^2
NM_003246 7057 THBS1 thrombospondin 1 2,75 0.89
NM_005630 6578 SLCO2A1 solute carrier organic anion transporter family, member 2A1 2,64 0.77
X62048 7465 WEE1 WEE1 homolog (S. pombe) 2,56 0.64
AY033606 57120 GOPC golgi associated PDZ and coiled-coil motif containing 2,54 0.72
NM_014187 29100 HSPC171 HSPC171 protein 2,47 0.96
NM_002709 5500 PPP1CB protein phosphatase 1, catalytic subunit, beta isoform 2,44 0.84
NM_005032 5358 PLS3 plastin 3 (T isoform) 2,36 0.58
NM_021977 6581 SLC22A3 solute carrier family 22 (extraneuronal monoamine transporter), 
member 3
2,36 0.99
AF220030 117854 TRIM6 tripartite motif-containing 6 2,33 0.76
NM_018695 55914 ERBB2IP Erbb2 interacting protein 2,31 0.72
NM_004735 9208 LRRFIP1 leucine rich repeat (in FLII) interacting protein 1 2,27 0.83
NM_018561 25862 USP49 ubiquitin specific peptidase 49 2,25 0.74
NM_032812 84898 PLXDC2 plexin domain containing 2 2,20 0.92
NM_004718 9167 COX7A2L cytochrome c oxidase subunit VIIa polypeptide 2 like 2,20 0.84
NM_016651 51339 DACT1 dapper, antagonist of beta-catenin, homolog 1 (Xenopus laevis) 2,20 0.97
AK056277 152048 FLJ31715 hypothetical protein FLJ31715 2,20 0.67
NM_004643 8106 PABPN1 poly(A) binding protein, nuclear 1 2,18 0.64
NM_000876 3482 IGF2R insulin-like growth factor 2 receptor 2,17 0.97
AF326917 26053 AUTS2 autism susceptibility candidate 2 2,16 0.64
NM_003685 8570 KHSRP KH-type splicing regulatory protein (FUSE binding protein 2) 2,14 0.52
NM_001300 1316 KLF6 Kruppel-like factor 6 2,12 0.81
NM_022823 64838 FNDC4 fibronectin type III domain containing 4 2,12 0.70
NM_004663 8766 RAB11A RAB11A, member RAS oncogene family 2,10 0.97
NM_002210 3685 ITGAV integrin, alpha V (vitronectin receptor, alpha polypeptide, antigen CD51) 2,08 0.62
BC018067 9364 RAB28 RAB28, member RAS oncogene family 2,05 0.92
NM_021738 6840 SVIL supervillin -2,65 0.68
AB028981 23348 DOCK9 dedicator of cytokinesis 9 -2,40 0.67
NM_002993 6372 CXCL6 chemokine (C-X-C motif) ligand 6 (granulocyte chemotactic protein 2) -2,37 0.21
NM_002371 4118 MAL mal, T-cell differentiation protein -2,30 0.56
AF402776 114614 BIC BIC transcript -2,30 0.41
The expression of these transcripts depends on the TGFβ1 concentration used. The first 25 genes are directly related to the TGFβ1 dosage (d value 
higher than zero), the last five are inversely related (d value lower than zero). Columns show: the GenBank accession number, the EntrezGene ID, the 
Gene symbol, the gene's description, the "d score" calculated by the SAM software, and the correlation coefficient R2.BMC Genomics 2007, 8:383 http://www.biomedcentral.com/1471-2164/8/383
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ponent (CC) categories (Figure 3A), there was an over-
representation of the up-regulated proteins involved in
extracellular matrix modification and cell-cell adhesion
and of proteins localized in subcellular compartments of
the exocytotic pathway, confirming the importance of
these pathways in the EMT reprogramming process. The
differentially under-expressed genes belong to the CC
class of the apical and lateral plasma membranes, indicat-
ing the loss of the typical epithelial morphology and func-
tions of cells undergoing EMT.
Up-regulated genes are particularly over-represented in
the BP categories such as "morphogenesis" and "cellular
morphogenesis", as well as those belonging to develop-
mental processes such as "cell fate determination", "myo-
genesis", "regulation of development" and "muscle
development", indicating that an embryological program
could be awakened.
All the genes containing an EntrezGene ID (886) were
mapped to the KEGG database to define the signaling
pathways and cellular structures that can participate in the
EMT process. Only 267 were classified by the software,
nevertheless we identified 14 pathways with more than
nine differentially expressed genes that were downloaded
and saved (Additional file 2). Up- and down-regulated
genes were colored red, orange, blue and light blue (see
Material and Methods). A visual inspection of these path-
ways is useful in clarifying the specific (activator or inhib-
itor) role of the differentially expressed genes, obtaining
more detailed information than from the GO analysis
alone. In the "apoptotic" pathway, for instance (Addi-
tional file 2), both activators (which are up-regulated) and
repressors (which are down-regulated) were identified,
providing a clear picture of the cell death process.
The signal transduction pathways involved in EMT were
better detailed by KEGG analysis, while other processes
such as cell adhesion or cytoskeleton remodeling were
also identified using the GO. Seven important intracellu-
lar pathways were involved in the EMT process in our
model, i.e. TGFβ1/SMAD, MAPK, WNT, JAK/STAT, cal-
cium signaling pathways, the cell cycle and apoptosis.
TGFβ1 is known to activate a large group of genes through
both Smad-dependent and Smad-independent pathways
[8,9].
We hypothesize that the genes we identified may be
closely interconnected in the human interactome, gener-
ating a sort of "TGFβ1 interactome". We identified 449
differentially expressed proteins that interact either
directly or with undifferentially expressed proteins. The
connected component that we highlighted contains 2630
proteins (nodes) and 4183 edges with an averaged con-
nectivity degree of 3.15. The large number of proteins
belonging to the cluster identified makes the result note-
worthy and indicates that most of the genes regulated by
TGFβ1 at transcriptional level during EMT encode pro-
teins that work in a highly coordinated manner.
An analysis performed with the tYNA software [10] con-
firms that the distribution of the connectivity degree in
the network follows the power law characteristic of scale-
free networks (data not shown). These networks are typi-
cal of cell systems and the majority of nodes have few
links in such an arrangement, but a few nodes have
numerous links, thereby ensuring that the system is fully
connected. A few highly-interconnected nodes thus act as
hubs that shape the network's overall operation, but may
also represent sites of system vulnerability [11]. We
selected the proteins with a connectivity degree – i.e. the
number of edges incident on them – higher than 29, call-
ing these proteins "hubs". We identified 27 hubs. The
complete list of the hubs is given in Table 2. All these pro-
teins were differentially expressed and three of them,
PXN, SMAD3 and TGFBR1, interacted with more than 12
differentially expressed proteins. If we consider these 27
hubs and the proteins interacting directly with them, we
identify a sort of central core of the TGFβ1 interactome
(network) consisting of 1235 proteins (Figure 4), 115 of
which were differentially expressed. Using tYNA software,
moreover, we found that the hub proteins had the "short-
est path length" and were consequently closely connected
within the network – in fact, 24 of them interacted
directly.
The hubs could be categorized in different ways, e.g. on
the basis of a specific GO term being over-represented in
the protein group formed by the hub and the interacting
proteins. Some nodes, such as SMAD3, CDKN1A and
CCND1, interacting with proteins that belong to the same
cellular compartment, could be defined as "party hubs"
[12]. Other hubs, such as TGFBR1 and PXN, interact with
proteins that have a different cellular localization and
could be defined as "date hubs". Moreover, TGFBR1 and
PXN tend to interact with proteins that act as bridges with
other hubs, thus becoming more interconnected than
other proteins. As shown by Han et al. [12] in yeast, party
and date hubs may have different functions. In particular,
date hubs seem to take part in a wide range of integrated
connections required for the global organization of bio-
logical modules in the whole proteome network.
To validate the microarray data, RT/PCR was performed
for six selected genes belonging to the most relevant GO
categories identified by our analysis. The RNA samples
used for RT/PCR analysis were those used for the microar-
rays. The up-regulation of tenascin (TNC), fibronectin 1
(FN1), matrix metalloproteinase 2 (MMP2) and connec-BMC Genomics 2007, 8:383 http://www.biomedcentral.com/1471-2164/8/383
Page 6 of 15
(page number not for citation purposes)
tive tissue growth factor (CTGF) and the down-regulation
of SMAD3 and collagen IV were confirmed by the RT/PCR
experiments. All these genes proved to be similarly regu-
lated by TGFβ1 in all three stimulation experiments.
Discussion
We used the global gene expression profile approach to
identify context-dependent markers of the EMT obtained
from the long-term TGFβ1 treatment of HUTEC in pri-
mary culture. Based on our previous data, we had specu-
lated that the context-dependent EMT process we
obtained was a dedifferentiating event. One of the aims of
the present study was to further substantiate this hypoth-
esis.
Various studies have shown that genes with a similar
expression pattern frequently display common functions
and form networks of interacting proteins [13]. Assuming
that the genes identified in our experiments belong to the
TGFβ1-regulated pathways, we searched for interactions
between the proteins encoded by the differentially
expressed genes given in Additional file 1. We reasoned
that microarray analysis might identify only a part of the
complex TGFβ1 network, due to other effects such as post-
transcriptional regulation, so we used protein-protein
interaction data to identify proteins interacting with those
encoded by differentially expressed genes. We obtained a
single connected component (interactome) consisting of
2630 proteins and containing 449 differentially expressed
proteins that interact directly or with undifferentially
expressed proteins. This analysis is extremely useful not
only for detecting the network of interacting proteins that
respond to TGFβ1, but also for identifying the network
hubs, i.e. proteins with a high degree of connectivity that
could have a crucial role in response to TGFβ1. We identi-
fied 27 hubs with more than 29 edges incident on them
and encoded by genes found differentially expressed in
our experiments. Of the three hubs identified as having
more than 12 interactions with differentially expressed
genes, SMAD3 was classified as a party hub while TGFBR1
and PXN were considered as date hubs. As shown by Han
et al. [12] in yeast, party and date hubs might have mark-
edly different global properties in the interactome net-
work. In accordance with this model, TGFBR1 and PXN,
which interact with proteins that have a different cellular
localization, might represent global or "high level" con-
nectors between different biological modules and
SMAD3, which functions within a module, works at a
"lower level" in the organization of the proteome.
Among hubs, thrombospondin 1 (THBS1) – the principal
activator of the TGFβ1 peptide [14] – emerges because it
links a wide range of matrix proteins mediating their inter-
action with cell-surface receptors. Its central role is con-
firmed by the 35 links connecting this protein to the other
proteins in the interactome map. It could be considered as
a date hub in the TGFβ1 interactome, according to the def-
inition given by Han et al. [12]. In Figure 5, the topologi-
cal connections of THBS1 are magnified (A) and the
differentially expressed genes interacting with it are indi-
cated (B). Moreover, THBS1 is the gene that has the most
significant correlation with TGFβ1 dosage (Table 1).
THBS1, PLS3 and ITGAV are known to have a pivotal role,
both in cytoskeleton remodeling and in de novo extracel-
lular matrix synthesis, two of the most relevant processes
in EMT. The importance of these processes is highlighted
by the considerable number of differentially expressed
genes in the "extracellular matrix" and "cytoskeleton" GO
categories (Figure 2).
Gene Ontology annotation of differentially expressed genes Figure 3
Gene Ontology annotation of differentially expressed 
genes. Up-regulated (black bars) and down-regulated (gray 
bars) genes shown in Additional file 1 were analyzed using 
GoMiner software. In (A) and (B), genes are classified respec-
tively on the basis of Biological Process and Cellular Compo-
nent. Only classes with a p value lower than 0.01 (A) and 
0.05 (B) are reported.BMC Genomics 2007, 8:383 http://www.biomedcentral.com/1471-2164/8/383
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In the "extracellular matrix (EMC)" category, the different
regulation of the various collagen types emphasizes the
transition from an epithelial-like to a mesenchymal ECM.
The up-regulation of TNC and FN1, one of the hubs of the
TGFβ1 interactome, confirmed the switch to a mesenchy-
mal ECM. The laminin α chain was found differentially
down-regulated in our model, as in other EMT models [5],
while the β1 chain is up-regulated, as occurs in the pre-
condensed mesenchyma [15], suggesting that an embryo-
nal mesenchymal ECM is being synthesized. This
suggestion is reinforced by the types of integrins up-regu-
lated during EMT. In fact, the "ECM receptor interaction"
of the KEGG pathways (Additional file 2) reveals not only
the up-regulation of integrins generating the network for
mesenchymal cell adhesion (ITGA5 and ITGAV) [16], but
also – and above all – the strong over-expression of
ITGA11, which constitutes the receptor for the interstitial
collagens involved in cell migration and collagen reorgan-
ization on mesenchymal cells during development [17].
The "cytoskeleton" category is characterized by a large
number of up-regulated genes, some of which have a cru-
cial role in cytoskeleton remodeling. It is worth noting
that four hubs of the TGFβ1 network, i.e. filamin A, alpha
(FLNA), alpha 1 actin (ACTA1), paxillin (PXN) and beta
actin (ACTB), belong to this category.
"Morphogenesis" is the GO category with the largest
number of up-regulated genes, as shown clearly in Figure
3. The significance score assigned by the GOMiner soft-
ware is not very high, however, because this category is
one of the most represented in the microarray chip. It
should nonetheless be noted that some of the genes
belonging to this category are among the top ten up-regu-
lated differentially expressed genes (Additional file 1).
Stimulated by TGFβ1, HUTEC seem to reactivate the
developmental processes: this may point to a sort of stem-
ness of tubular cells that enables them to dedifferentiate
when stimulated (kidney repair and maintenance), but
also to reawaken a silenced embryogenetic program. Sox
11, GADD45B, N-cadherin (CDH2), Activin A (INHBA),
CTGF, FGF1/5, Angiopoietin (ANGPTL4), natriuretic pep-
tide precursor B (NPPB), calcitonin receptor (CALCR) and
caldesmon 1 (CALD1) are the most over-expressed genes
belonging to the "morphogenesis" category. That tubular
cells have the ability to reactivate an embryogenetic pro-
gram has been demonstrated very recently by Kitamura et
al. [18] and Maeshima et al. [19], who identified and iso-
Table 2: List of the TGFβ1 interactome hubs.
GB accession ID EntrezGene ID Gene Symbol Gene description Log ratio
AK002171 7046 TGFBR1 transforming growth factor, beta receptor I (activin A receptor type II-like 
kinase, 53 kDa)
1,04
NM_001456 2316 FLNA filamin A, alpha (actin binding protein 280) 0,77
NM_002026 2335 FN1 fibronectin 1 0,73
NM_001100 58 ACTA1 actin, alpha 1, skeletal muscle 0,62
NM_005157 25 ABL1 v-abl Abelson murine leukemia viral oncogene homolog 1 0,61
AK024230 7532 YWHAG tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, 
gamma polypeptide
0,61
NM_000389 1026 CDKN1A cyclin-dependent kinase inhibitor 1A (p21, Cip1) 0,60
NM_002859 5829 PXN paxillin 0,58
NM_053056 595 CCND1 cyclin D1 0,55
NM_004087 1739 DLG1 discs, large homolog 1 (Drosophila) 0,54
NM_006597 3312 HSPA8 heat shock 70 kDa protein 8 0,49
NM_004346 836 CASP3 caspase 3, apoptosis-related cysteine peptidase 0,45
NM_003029 6464 SHC1 SHC (Src homology 2 domain containing) transforming protein 1 0,45
NM_005658 7185 TRAF1 TNF receptor-associated factor 1 0,44
NM_032904 5781 PTPN11 protein tyrosine phosphatase, non-receptor type 11 (Noonan syndrome 1) 0,42
NM_005544 3667 IRS1 insulin receptor substrate 1 0,25
NM_003246 7057 THBS1 thrombospondin 1 0,20
NM_005243 2130 EWSR1 Ewing sarcoma breakpoint region 1 -0,46
NM_003177 6850 SYK spleen tyrosine kinase -0,48
NM_021105 5359 PLSCR1 phospholipid scramblase 1 -0,48
NM_001753 857 CAV1 caveolin 1, caveolae protein, 22 kDa -0,50
AF130085 1499 CTNNB1 catenin (cadherin-associated protein), beta 1, 88 kDa -0,56
NM_015400 4088 SMAD3 SMAD, mothers against DPP homolog 3 (Drosophila) -0,62
NM_001101 60 ACTB actin, beta -0,63
NM_007315 6772 STAT1 signal transducer and activator of transcription 1, 91 kDa -0,94
AK024192 11030 RBPMS RNA binding protein with multiple splicing -0,97
NM_000633 596 BCL2 B-cell CLL/lymphoma 2 -1,41
Columns show: the GenBank accession number, the EntrezGene ID, the Gene symbol, the gene's description and the geometric mean of the log2 ratio 
given in Additional file 1, column N, indicating the level of gene expression.BMC Genomics 2007, 8:383 http://www.biomedcentral.com/1471-2164/8/383
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Cluster of interacting proteins Figure 4
Cluster of interacting proteins. The TGFβ1 network consists of 27 hub proteins with more than 29 edges incident on 
them and proteins that interact directly with them identified in the "TGFβ1 interactome". The hubs are clearly visible in the 
network from their high degree of connectivity. Proteins encoded by up-regulated and down-regulated genes are 115 and 
colored respectively in red and green using a color gradient reflecting the mean log2 ratio given in Additional file 1, column N. 
This TGFβ1 core consists of 1235 proteins.BMC Genomics 2007, 8:383 http://www.biomedcentral.com/1471-2164/8/383
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lated cells of the S2 segment with a potential tubulogenic
ability and a capacity for integration in the developing
kidney. Our results are in line with their findings.
CD133+ cells have been found to have stem cell potential
in the adult kidney [20]. Hypothesizing that CD133 up-
regulation should occur if a stemness property is activated
by TGFβ1, we looked specifically for prominin 1 (CD133)
mRNA activation in our EMT model. Surprisingly, we
found CD133 down-regulated, indicating that CD133 is
expressed in control conditions. This finding supports the
view taken by Florek et al. [21], who showed that pro-
minin 1 transcript and the alphahE2 epitope immunore-
activity of CD133 (obtained using a novel antibody
instead of AC133) occur in several adult tissues and in the
proximal tubular cells of the adult kidney in particular.
Signaling members of the Wnt (WNT5B) and FGF (1/5)
families and transcription factors such as Sox 11, known
to have a crucial role in nephrogenesis and cell fate deter-
mination during kidney development [22,23], were
found up-regulated. The involvement of the Wnt pathway
was also confirmed by KEGG analysis.
The non-canonical Wnt signaling pathway centered on
WNT5/Ca2+ [24,25] seems to be activated through Nemo-
like kinase (NLK) in our EMT model and to antagonize
the canonical beta-catenin Wnt signaling (Additional file
2). In fact, we observed the down-regulation of both wing-
less-type MMTV integration site family, member 2B
(WNT2B) and catenin, beta 1 (CTNNB1) and the up-reg-
ulation of both WNT5B and the calcium signaling path-
way (see KEGG pathways). This effect seems to be
reinforced by the up-regulation of dapper, antagonist of
beta-catenin, homolog 1 (DACT1), which is a known
beta-catenin Wnt signal inhibitor. It has been reported
that inhibiting the beta-catenin system strongly inhibited
TGFβ1-induced  αSMA expression in tubular cells [26].
Our data confirm this finding, since no αSMA expression
was triggered by TGFβ1 in our EMT model [6].
The non-canonical Wnt pathway, which includes planar
cell polarity – an important process in embryonal axis
development involving cytoskeletal polarity, as well as in
the calcium pathway regulating cell adhesion [24]-, was
thus found up-regulated in our EMT model, reinforcing
the idea that an embryological program is awakened. Very
recently, Osafune et al. [25] reported that the capacity of
renal progenitor cells of the metanephric mesenchyme to
form colonies in vitro and undergo mesenchymal-epithe-
lial transition is positively regulated by planar cell polarity
pathways downstream from Wnt.
Although the canonical Wnt signaling was repressed, the
final effector of the pathway – and one of the most impor-
tant – Cyclin D1 (CCND1) was up-regulated, whereas
Cyclin B2 (CCNB2) – which is assumed to bind to TGFβ
R2 and thus play a key part in TGFβ-mediated cell cycle
control – was down-regulated.
Apoptosis and EMT are two distinct and opposite signal
modules for TGFβ1-downstream effects. There is growing
evidence that SMAD3 is an important signaling anchor for
the apoptotic network for TGFβ1 too. In particular, the
loss of SMAD3 function due to a decrease in its expression
might be a requirement for epithelial cells to survive in the
presence of prolonged TGFβ1 stimulation [27]. This was
also confirmed in our EMT model: visual inspection of the
TGFβ-SMAD KEGG pathway (Additional file 2) reveals
what we demonstrated previously using RT/PCR analysis
[6], i.e. that Smad signaling was down-regulated. Despite
Topological connections of the date hub THBS1 Figure 5
Topological connections of the date hub THBS1. 
Thrombospondin 1 (THBS1) links directly 35 proteins in the 
TGFβ1 interactome: A) the topological connections are 
shown; B) the proteins encoded by differentially expressed 
genes are indicated and colored respectively in red and green 




gray: extracellular matrix, extracellular space 
pink: membrane 




Gene name         mean log2 ratio
SPARC              0.84 
CD47                -0.55 
 FN1                   0.73 
MMP9               0.72 
IGFBP5             0.91 
COL5A1            0.72 
COL1A1            0.61 
THBS1               0.2 
MMP2               1.58 
DHFR               -0.78 
ITGAV              0.88 BMC Genomics 2007, 8:383 http://www.biomedcentral.com/1471-2164/8/383
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the number of up-regulated inducers (TGFβ1, INHBA),
the key transducers are all down-regulated, as are the Id
genes (the effectors of cell differentiation). The ID2B gene
was specifically down-regulated. Mad expression and ID2
down-regulation are important events in the TGFβ1 cyto-
static program in epithelial cells and ID2 suppression by
TGFβ1 is essential for EMT to occur [28,29].
The central role of SMAD3 is also demonstrated by its
position in the TGFβ1 network: it is one of the hubs, most
likely a date hub since it works within a single module
(Figure 6), at a low level of network organization. This
might explain why apoptosis seems to be induced in our
model, despite SMAD2 and SMAD3 down-regulation. In
fact, a visual inspection of the KEGG apoptosis pathway
clearly shows the up-regulation of caspase 3 (CASP3), a
known inducer of cell death, and the under-expression of
BCL2 and BIRC3 (IAP gene in the KEGG map), which
counteract this action.
On the other hand, the up-regulation of several genes
implicated in the cell cycle pathway (Additional file 2),
such as CCND1, GADD45, YWHAG (tyrosine 3-monoox-
ygenase/tryptophan 5-monooxygenase activation pro-
tein), indicates that cells are entering the cell cycle. In this
pathway, however, the up-regulation of wee1 tyrosine
kinase (WEE1), one of the genes strictly regulated by
TGFβ1, seems to indicate a sort of actual control of cell
proliferation, so both apoptosis and cell cycle entry seem
to be strictly controlled in the EMT process. Indeed, nei-
ther apoptosis nor proliferation were seen in our model
by immunocytochemistry [6]. It is tempting to speculate
that a concerted and strictly controlled action between sig-
nals for cell death and proliferation might be taking place
in cells after long-term TGFβ1 exposure, miming the
developmental process in which morphogens such as
TGFβ1 act not as positive regulators of cell differentiation
but as key regulators of cell survival [30]. It is worth not-
ing that key proteins of the Wnt signaling and apoptosis/
cell cycle control pathways (i.e. CTNNB1, CCND1,
CASP3, BCL2) were found to constitute some of the hub
proteins of the TGFβ1 network.
Finally, KEGG analysis of microarray data highlighted that
RAS/MAPK signaling was the principal downstream effec-
tor of chronic TGFβ1 stimulation in our EMT model, con-
firming the suggestions advanced by other authors [5,8],
i.e. that both Smad-dependent and Smad-independent
signaling cascades are activated by TGFβ1 and that they
regulate mesenchymal transition in a context- and cell-
dependent manner. The MAPK signaling pathway has an
important role in connecting the signal triggered by
TGFβ1 to important downstream processes such as apop-
tosis/proliferation and the Wnt cascade [5]. Our results
confirm reports from other authors on the role of this sig-
naling in other EMT processes [31-33].
Conclusion
Understanding how mesenchymal cells arise from epithe-
lial cells could have a strong impact in unveiling the
mechanism behind fibrosis and cancer progression. More-
over, it might reveal mechanisms of epithelial cell plastic-
ity underlying kidney regeneration and repair.
In the kidney, tissue regeneration and repair occur
through three, not mutually exclusive, cellular and molec-
ular mechanisms: differentiation of the somatic stem
cells, recruitment of circulating stem cells and, more
importantly, proliferation/dedifferentiation of mature
cells. Dedifferentiation seems to represent a critical step
for the recovery of tubular integrity and precedes the
reconstitution of a well-differentiated morphology.
Understanding the cellular and molecular events involved
in renal tubule regeneration is indispensable to design
cell-based and other therapeutic strategies in order to
potentiate this innate capacity. EMT is now considered a
part of tubular cell plasticity.
The purpose of our study was to substantiate our initial
hypothesis that the process of EMT induced by TGFβ1
chronic exposure in HUTEC is a dedifferentiating process.
Our earlier results suggested that this might be so and our
present findings support that impression. In fact: 1) the
principal functional category involved in the EMT process
concerns morphogenesis and development; 2) the most
up-regulated genes belong to this category; and, finally, 3)
some intracellular pathways are involved, whose engage-
ment during kidney development and nephrogenesis is
well known. Our results thus suggest that the recapitula-
tion of embryological programs is an integral part of the
EMT process on long-term exposure to TGFβ1 and that
tubular cells may have the capacity, under appropriate
environmental cues, to redifferentiate not only back to an
epithelial type but also towards another cell type, i.e.
myofibroblasts or endothelial cells. Judging from our
data, moreover, TGFβ1 seems (in the context of our exper-
iments) to act as a morphogen regulating cell survival by
means of strictly balanced signals for cell death and pro-
liferation.
Finally, our findings are the first to show that genes
involved in the TGFβ1-driven EMT process are highly
interconnected and topologically related in the human
interactome map. They generate a single scale-free net-
work whose hub proteins were found differentially
expressed, pointing to a crucial role for them in the EMT
process. The main role of one of them, thrombospondin
1, emerges from its high degree of regulation by TGFβ1BMC Genomics 2007, 8:383 http://www.biomedcentral.com/1471-2164/8/383
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and from the 35 links connecting this protein to the other
proteins in the interactome map.
Methods
Cell cultures
Primary HUTEC cultures were established as explained
elsewhere [6]. Cells at passage 1 were used for TGFβ1
stimulation experiments, designed to monitor the effect
of TGFβ1 at both phenotypic and molecular levels simul-
taneously [6]. Cells were seeded at subconfluence and
incubated at 37°C in a 5% CO2 atmosphere for 24 hrs
under quiescent conditions (1% FCS in RPM1 1640) in 6-
well plastic or collagen I-coated plates for RNA extraction.
Cells were cultured for 4 days in the presence of 1, 5, 10,
50 ng/ml human TGFβ1 (Prepro Tech EC, London, UK).
Stimulation experiments were conducted in triplicate and
morphological, immunocytochemical and molecular
analyses were performed. Control conditions were repre-
sented by cells maintained for 4 days in 1% serum with-
out TGFβ1.
RNA extraction and quality control
Total RNA was extracted using RNAzolB (BIOTEX, Hou-
ston, USA) according to the protocol.
The Agilent 2100 Bioanalyzer (Agilent Technologies, Pal-
oAlto, USA) was used to assess RNA integrity. RNA was
quantified with the UV/VIS Spectrometer (Lambda 2S
PerkinElmer).
Microarray platform
Microarray expression was analyzed using the Operon 70
mer oligos collection (Human Version 2.0) containing
21,329 oligonucleotides spotted in duplicate
(GPL2136136 record in the GEO database) on MICRO-
MAX glass slides – SuperChip I provided by PerkinElmer
Life Sciences Inc. (Boston, USA).
Oligos were printed using the Biorobotics Microgrid II
spotter; spots were spaced 115 μm and microarrays con-
sisted of 48 subarrays.
RNA amplification and labeling
1 μg of total RNA was amplified using the Amino Allyl
MessageAmp™ aRNA Kit (Ambion, Austin, USA). Five μg
of amplified RNA (aRNA) were labeled with Cy3/Cy5
fluorophores using CyDye Post Labeling Reactive Dyes
(Amersham Biosciences, Piscataway, USA).
Following purification, dye incorporation was quantified
by spectrophotometric analysis.
Hybridization
Approximately 2.5 μg of aRNA labeled with 100 pmoles
of fluorophore were used for each hybridization.
Labeled aRNA was precipitated using NH4Ac and EtOH
following standard protocols and resuspended in hybrid-
ization buffer (5× SSC; 0.1% SDS; 40 ng/μl SS-DNA; 25%
formamide).
Microarray slides were pre-hybridized in GeneMachines™
chambers (Genomic Solutions, Cambs., UK) for 2 h at
48°C with 70 μl of pre-hybridization buffer (5× SSC;
0.1% SDS; 40 ng/μl SS-DNA; 1× Denhardt's solution)
using a coverslip.
Slides were washed with water and dried with compressed
air.
Hybridization was carried out using Hybridization Sta-
tion ArrayBooster™ (Advalytix, Brunnthal, Germany) at
48°C for 12 h.
Topological connections of the party hub SMAD3 Figure 6
Topological connections of the party hub SMAD3. 
SMAD3 links directly 119 proteins in the TGFβ1 interac-
tome: A) the topological connections are shown; B) the pro-
teins encoded by differentially expressed genes are indicated 
and colored respectively in red and green using a color gradi-
ent reflecting the mean log2 ratio reported in the square.
gray: extracellular matrix, extracellular space 
pink: membrane 






Gene name         mean log2 ratio
RRAS2                  0,35               
SPTBN1                0,97              
TGFBR1                1,04               
FLNA                    0,77 
CTNNB1              -0,56 
RIT1                      0,70 
WEE1                    0,54 
ANK3                    0,57 
TCF8                     0,88 
PAPPA                  0,66 
SMAD3               -0,62 
EBI3                    -0,72 
FOXO1A              0,97BMC Genomics 2007, 8:383 http://www.biomedcentral.com/1471-2164/8/383
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Microarrays were washed with 1× SSC plus 0.2% SDS for
4 minutes, 0.1× SSC plus 0.2% SDS for 4 minutes, twice
with 0.2× SSC for 4 minutes, and twice with 0.1× SSC for
3 minutes.
Microarray scanning and image analysis
Microarrays were scanned using ScanArray Lite (Perk-
inElmer™). Images were analyzed using ScanArray Express
(PerkinElmer™).
Statistical analysis
The following procedure was used to remove spots with a
low fluorescence intensity or high variability between rep-
licates.
1) "Intensity-dependent calculation of standard Z-score"
spots with a median fluorescence pixel intensity below
700 (calculated considering negative control intensity) on
both Cy3 and Cy5 channels were filtered out; those with
a median fluorescence pixel intensity of zero or less in
only one channel were set to 100 to prevent their elimina-
tion during normalization. Files were saved in "tav" for-
mat to make them suitable for reading with MIDAS
software [34] and normalization was done using the
LOWESS method.
Two different procedures (named A and B) were used to
eliminate outliers, as follows.
(A) Based on the method suggested by Yang et al. [35], we
calculated R1 = (CH1 intensity/CH2 intensity) and R2 =
(CH1 intensity/CH2 intensity) values for the two repli-
cates of the same gene on the microarray and log2(R1/R2).
We indicated the two replicates of the spot as R1 and R2.
Then we calculated the mean and SD (standard deviation)
for the log2(R1/R2) values of all microarray spots. Those
with a log2 ratio higher than |3 SD| were rejected due to
replicate inconsistency.
The geometric mean for the two replicates of the remain-
ing genes was calculated and the output files were saved in
"tav" format.
(B) The "tav" file for each microarray experiment was nor-
malized using MIDAS software and geometric mean val-
ues underwent SLICE data analysis, considering only
those where |log2(CH1 intensity/CH2 intensity)|≥1.5 SD.
Each experiment was performed in duplicate using a dye
swap procedure and only the genes that independently
complied with these filters on both replicates were consid-
ered.
2) "SAM analysis"
data were also analyzed using SAM software, but intra-
array replicates were not averaged, intensity fluorescence
filtering was as described previously and normalization
was done using the LOWESS procedure. The four repli-
cates (two intra-array and two deriving from the dye-swap
analysis) were t-tested using the SAM software and consid-
ering the lowest False Discovery Rate.
In all, 1203 spots were considered at this stage: 589 of
them satisfied both statistical procedures 1) and 2) in at
least one of the seven experiments (collagen 5–10–50,
plastic 5–10–50 and collagen vs. plastic) and 614 spots
were identified by the SAM software alone. The geometric
mean was calculated from the four replicates of each gene
and is given in Additional file 1 (columns G-L). Some
genes, especially those identified only by the SAM soft-
ware and in the "50 ng of TGFβ1" experiments, had a low
(<0.65) log2  ratio and were filtered out. We finally
obtained 993 differentially expressed spots, correspond-
ing to 977 genes (some oligos refer to the same gene),
given in Additional file 1. This table consists of two parts:
spots 1 to 554 are the most significant because they satisfy
both statistical procedures 1) and 2); genes from 555 to
993 are less significant because they only passed the SAM
analysis.
We also used the "quantitative response" option of the
SAM software to check for the presence of genes whose
expression is regulated in a dose-dependent manner
(Table 1).
Validation of microarray data
RT/PCR-Real Time PCR
six differentially expressed genes belonging to the differ-
ent GO categories found involved in the EMT process, i.e.
TNC, FN1, collagen IV, MMP2, SMAD3 and CTGF, were
analyzed. Quantitative comparative RT/PCR and Real
Time RT/PCR were performed, as reported elsewhere [6].
Immunocytochemistry
immunocytochemistry was conducted, using antibodies
against αSMA, cytokeratin 8–18, vimentin, collagen III,
Ki67 and E-cadherin, as described in [6].
Annotation checking procedure
The annotation of the Human Version 2.0 microarray
platform (OPERON) was out of date, so we double-
checked it using the MatchMiner software [36], loading
the GenBank accession numbers and recovering the Ent-
rezGene ID and the gene symbol (only for the genes in
Additional file 1). If the GenBank clone had been with-
drawn, we performed a BLAST search with the oligo
sequence on the UCSC Genome Browser [37] and we
updated the GenBank ID. This search was also conductedBMC Genomics 2007, 8:383 http://www.biomedcentral.com/1471-2164/8/383
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for the RefSeq sequences with multiple associations. Oli-
gos matching more than one gene were rejected. To verify
gene symbols and gene descriptions, we downloaded the
"gene_info.gz" file from the NCBI ftp site [38].
Functional analysis of microarray data
Geometric mean expression values of the 993 spots iden-
tified were obtained for each of the seven experiments and
these data were clustered using TMEV software [34].
Functional categories were identified with the GoMiner
software [39] using the Gene Ontology (GO) annotation
[40]. We selected a p value threshold of 0.02 for Biological
Process categories and 0.05 for the Cellular Component.
To identify KEGG pathways involved in the TGFβ1
response we colored up- or down-regulated genes with the
tool available on the KEGG site [41,42]. Differentially
expressed genes that only passed the SAM analysis were
colored orange (up-regulated) or light blue (down-regu-
lated); genes that passed both statistical analyses (see
Methods) were colored red (up-regulated) or blue (down-
regulated).
Mapping the differentially expressed genes in the human 
interactome
We used data from the literature on protein-protein inter-
actions to verify whether the genes in Additional file 1 are
independent or tend to be associated with one another in
one or more clusters. We downloaded the protein-protein
interactions from three different sources, i.e. (A) the NCBI
ftp site [43] (interactions.gz), from which we selected the
interactions identified in Homo sapiens and used a Perl
script to assign the official symbol to the known proteins;
(B) the BioGRID database [44]; and (C) the Biomolecular
Interaction Network Database (BIND) [45]. Each data set
was loaded separately in the Cytoscape software [46] and
three distinct "global" protein-protein interaction net-
works were generated. For each global network we
mapped the genes identified in our microarray experi-
ments (Additional file 1) and selected proteins that inter-
act with them directly, generating a small group of sub-
networks. We selected only the three largest sub-networks
and they were merged into a single subnetwork using the
"union" function in Cytoscape. The network we obtained
is composed of 2630 nodes and 4183 edges. We used the
"filter option" in Cytoscape to select the nodes interacting
with more than 29 proteins. These nodes were called
hubs. Gene Ontology analysis was performed on the net-
work using BINGO software [47], while network topolog-
ical statistics were obtained using tYNA software [10]. The
interactome was also deposited in the tYNA database [48]
(TGFbeta-network-231106). Microarray experiments
were loaded into ArrayExpress with accession number E-
MEXP-566 according to the MIAME rules [49].
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List of differentially expressed genes. Genes numbered from 1 to 554 
(column A) passed both statistical analyses (SAM and "intensity-depend-
ent calculation of standard Z-score", see Methods), those numbered from 
555 to 993 passed only the SAM analysis. The other columns show: (B) 
the OPERON oligo ID in the OMAD database [50]; (C) the EntrezGene 
ID; (D) the Gene Symbol; (E) the description of the gene ; (F) genes 
belonging to the cluster of interacting genes in Figure 3, marked "1"; (G-
L) genes up-regulated in cells treated with TGFβ1 have log2 values higher 
than 0, genes down-regulated have values lower than 0 (values that 
passed the statistical analysis are in bold); (M) genes up-regulated in the 
plastic substrate by comparison with the collagen type I have values higher 
than 0, genes down-regulated have values lower than 0; (N) geometric 
means of the experiments in columns (G-L).




KEGG analysis of differentially expressed genes. 267 genes in Addi-
tional file 1 with an EntrezGene ID were placed in the KEGG maps using 
the "color genes" option in the KEGG database [41]. Differentially 
expressed genes that only passed the SAM analysis were colored orange 
(up-regulated) and light-blue (down-regulated); genes that passed both 
statistical analyses (see Methods) were colored red (up-regulated) and 
blue (down-regulated).
Click here for file
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